|Bid||0.7200 x N/A|
|Ask||0.7300 x N/A|
|Day's Range||0.7100 - 0.7400|
|52 Week Range||0.4000 - 1.6500|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr. 05, 2019 - Apr. 08, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.25|
LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience.The Planet MicroCap Showcase: VIRTUAL begins on Tuesday, April 20, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders on current hot themes, including: SPACs, Cryptocurrency, Digital Assets, Cannabis, Psychedelics, and of course, Small-, Micro- and Nano-Cap investing.
TORONTO, ON / ACCESSWIRE / April 19, 2021 / StageZero Life Sciences (TSX:SZLS), a company dedicated to early detection of multiple disease states through whole blood, today announced that it will be presenting at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22 at 8:30 AM EST. James Howard-Tripp, Chairman and CEO of StageZero will be hosting the presentation and answering questions from investors.
TORONTO, ON / ACCESSWIRE / April 5, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") on Thursday April 1st, announced it was partnering with Health Clinics and Care Oncology to launch the early cancer diagnostic program AVRT centered around Aristotle, StageZero's multi-cancer test.The Aristotle Female panel is 9 tests for cancer: ovarian, breast, cervical, endometrial, colorectal, bladder, stomach, liver and nasopharyngeal.